BR112013016998A2 - emplastro medicamentoso para a permeação transdérmica melhorada de diclofenaco dietilamônio - Google Patents

emplastro medicamentoso para a permeação transdérmica melhorada de diclofenaco dietilamônio

Info

Publication number
BR112013016998A2
BR112013016998A2 BR112013016998A BR112013016998A BR112013016998A2 BR 112013016998 A2 BR112013016998 A2 BR 112013016998A2 BR 112013016998 A BR112013016998 A BR 112013016998A BR 112013016998 A BR112013016998 A BR 112013016998A BR 112013016998 A2 BR112013016998 A2 BR 112013016998A2
Authority
BR
Brazil
Prior art keywords
transdermal permeation
diclofenac diethylammonium
improved transdermal
medicated patch
diethylammonium
Prior art date
Application number
BR112013016998A
Other languages
English (en)
Portuguese (pt)
Inventor
Francesco Cilurzo
Paola Minghetti
Original Assignee
Pharmafilm S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmafilm S R L filed Critical Pharmafilm S R L
Publication of BR112013016998A2 publication Critical patent/BR112013016998A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
BR112013016998A 2010-12-29 2010-12-29 emplastro medicamentoso para a permeação transdérmica melhorada de diclofenaco dietilamônio BR112013016998A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2010/070882 WO2012089256A1 (en) 2010-12-29 2010-12-29 Medicated patch for improved transdermal permeation of diclofenac diethylammonium

Publications (1)

Publication Number Publication Date
BR112013016998A2 true BR112013016998A2 (pt) 2016-10-25

Family

ID=44624959

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013016998A BR112013016998A2 (pt) 2010-12-29 2010-12-29 emplastro medicamentoso para a permeação transdérmica melhorada de diclofenaco dietilamônio

Country Status (5)

Country Link
EP (1) EP2658576A1 (de)
CN (1) CN103384533A (de)
BR (1) BR112013016998A2 (de)
EA (1) EA201390980A1 (de)
WO (1) WO2012089256A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3474831A1 (de) 2016-06-23 2019-05-01 Corium International, Inc. Haftende matrix mit hydrophilen und hydrophoben bereichen und einem therapeutischen wirkstoff
KR20230109782A (ko) 2016-07-27 2023-07-20 코리움, 엘엘씨 아민 약물의 나트륨 바이카보네이트 제자리 전환 구동된경피성 전달
US11173132B2 (en) 2017-12-20 2021-11-16 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
IT202000011686A1 (it) * 2020-05-20 2021-11-20 Fidia Farm Spa Cerotto medicato a lento rilascio

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
KR19990026792A (ko) * 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
DE19812413C1 (de) * 1998-03-20 1999-06-10 Sanol Arznei Schwarz Gmbh Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend

Also Published As

Publication number Publication date
WO2012089256A1 (en) 2012-07-05
EP2658576A1 (de) 2013-11-06
CN103384533A (zh) 2013-11-06
EA201390980A1 (ru) 2013-11-29

Similar Documents

Publication Publication Date Title
IL272718B (en) History of 11-hydroxyl of bile acids and their conjugates with amino acid as paranoid x receptor modulators
CR20110407A (es) Dicianopiridinas alquilamino-sustituidas y sus profármacos de éster de aminoácido
DK2596786T3 (da) Anvendelse af eicosapentaensyreethylester til behandling af hypertriglyceridæmi
CR20120413A (es) Derivados de fumarato de ácido graso y sus usos
EA201390804A1 (ru) Лекарственная форма лакозамида для приема один раз в сутки
BR112015014253A2 (pt) produtos de higiene bucal que compreendem um complexo de haleto de aminoácido e zinco tetrabásico
CO6811816A2 (es) Composiciones que contienen, métodos que involucran, y usos de derivados de dolastatina unidos a aminiácidos no naturales
BRPI0915300B8 (pt) compostos de éster boronato e composições farmacêuticas dos mesmos
MX2020003096A (es) Formulaciones farmaceuticas de un inhibidor de hidroxilasa de hif.
BR112013000776A2 (pt) método e formulação para tratamento de deficiência de ácido siálico
CO6710913A2 (es) Uso de ácido lipasa lisosomal para tratar la deficiencia de ácido lipasa lisosomal en pacientes
BR112015005369A2 (pt) inibidores de usp30 e métodos para sua utilização
BR112014014212A2 (pt) composições contendo película
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
BR112013016998A2 (pt) emplastro medicamentoso para a permeação transdérmica melhorada de diclofenaco dietilamônio
AU343717S (en) Sticking plaster used for medical purposes
GT201300270A (es) Formulaciones de liberacion sostenida de paracetamol
BR112014017587A2 (pt) métodos e formulações para o tratamento de deficiências de ácido siálico
EA201490041A1 (ru) Пластырь, содержащий диклофенак и тиоколхикозид
BR112014015225A8 (pt) novo éster de ácido graxo, novo emoliente, e, uso de um éster de ácido graxo
BR112012024239A2 (pt) composição para tratamento de trombocitemia essencial
BR112013025766A2 (pt) composições farmacêuticas de liberação modificada de desvenlafaxina
BR112013016144A2 (pt) composição de revestimento curável por umidade de cura em baixa umidade e método para uma composição de revestimento curável por umidade de cura em condições de baixa umidade
BR112012024649A2 (pt) uso de uma composição e compósição definida para uso em um touro
CO6751261A2 (es) Parche medicado para mejorar la penetración transdérmica del diclofenaco dietilamonio

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)